Effect of a 12-month Pharmaceutical Care Program on Control of Severe Asthma

Effect of a 12-month Pharmaceutical Care Program on Severe Asthma Patient. A Randomized Clinical Trial

Only a few well-designed studies have investigated the effect of pharmaceutical care on asthma patients and to date there are no published studies investigating this effect specifically on severe and refractory asthma.

The objective of this study is evaluate the effect of pharmaceutical care on asthma control and quality of life (QoL) of patients with severe or refractory asthma compared with pharmacist dispensation only.

Inclusion Criteria:

• Patients with severe/refractory asthma presenting other respiratory disease,
• ≥ 18 years of age,
• using high dose of inhaled corticosteroids (≥ 800mcg of budesonide or equivalent)
• FEV1<60%,
• regular visitor of the pharmacy and the physicians.

Exclusion Criteria:

• participation in other intervention study during this study,
• living in other cities,
• could not participate in all visits of the study